Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study.
We evaluated the effect of saphenous-vein-bypass grafting on survival in patients with chronic stable angina by comparing medical and surgical treatment in a large-scale, prospective randomized study. Excluding patients with left-main-coronary-artery disease who have already been reported, a total of 596 patients were entered into this study; when randomized into a medical group (310 patients) and a surgical group (286 patients), entry clinical and angiographic base lines were comparable. Operative mortality at 30 days was 5.6 per cent. At an average of one year after operation, 69 per cent of all grafts were patent, and 88 per cent of the surgical patients had atleast one patent graft. There was no statistically significant difference in survival, at a minimal follow-up interval of 21 months, between patients treated medically and those treated with saphenous-vein-bypass grafting. At 36 months, 87 per cent of the medical group and 88 per cent of the surgical group were alive.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D002908:Chronic Disease; D001026:Coronary Artery Bypass / Q000401:mortality; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012306:Risk; D012501:Saphenous Vein / Q000637:transplantation; D014182:Transplantation, Autologous; D014481:United States; D014493:United States Department of Veterans Affairs